Temple Polyclinic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 19.48%
(FY 2022)
- Ebitda 14.62%
(FY 2022)
- Net Worth -5.73%
(FY 2022)
- Total Assets -26.34%
(FY 2022)
About Temple Polyclinic
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kakoli Burman, Sumita Chakraborty, and Anish Chakraborty serve as directors at the Company.
- CIN/LLPIN
U85195WB2001PTC093133
- Company No.
093133
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- LocationNa, West Bengal
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Temple Polyclinic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kakoli Burman  | Additional Director | 10-Mar-2017 | Current |
| Sumita Chakraborty | Director | 24-Apr-2001 | Current |
| Anish Chakraborty | Director | 24-Apr-2001 | Current |
Financial Performance of Temple Polyclinic.
Temple Polyclinic Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 19.48% increase in profit. The company's net worth dipped by a decrease of 5.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Temple Polyclinic?
In 2015, Temple Polyclinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Seacom Projects LimitedActive 17 years 7 monthsKakoli Burman, Sumita Chakraborty and 1 more are mutual person
- Prativa Agro Product Private LimitedActive 16 years 7 months
Sumita Chakraborty and Anish Chakraborty are mutual person
- Ess Lahiri & Co Pvt LtdActive 67 years 6 months
Sumita Chakraborty and Anish Chakraborty are mutual person
- Advent Multiservices Private LimitedActive 26 years 10 months
Sumita Chakraborty and Anish Chakraborty are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Temple Polyclinic?
Unlock and access historical data on people associated with Temple Polyclinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Temple Polyclinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Temple Polyclinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
